| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |